GB2359554A — C-Glycosides and preparation thereof as antidiabetic agents
Assigned to Kotobuki Seiyaku Co Ltd · Expires 2001-08-29 · 25y expired
What this patent protects
A compound of formula (I), <EMI ID=2.1 HE=37 WI=92 LX=525 LY=566 TI=CF> <PC>wherein <EMI ID=2.2 HE=68 WI=105 LX=369 LY=1074 TI=CF> <PC><U>---</U> means a saturated or unsaturated carbon bond;<BR> m is 0 or1;<BR> n is 0, 1 or 2;<B…
USPTO Abstract
A compound of formula (I), <EMI ID=2.1 HE=37 WI=92 LX=525 LY=566 TI=CF> <PC>wherein <EMI ID=2.2 HE=68 WI=105 LX=369 LY=1074 TI=CF> <PC><U>---</U> means a saturated or unsaturated carbon bond;<BR> m is 0 or1;<BR> n is 0, 1 or 2;<BR> A<SB>1</SB> is<BR> in which m is O, R<SB>3</SB> is lower alkyl, and when m is 1, R<SB>3</SB> is lower alkyl, -OH or -O-lower alkyl;<BR> or a pharmaceutical acceptable salt thereof. The compounds or salts are useful for the treatment and/or prevention of diabetes and hypoglycemia.
Drugs covered by this patent
- Invokana (CANAGLIFLOZIN) · Johnson & Johnson
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.